Xiaowei Qi

5.4k total citations · 1 hit paper
199 papers, 3.8k citations indexed

About

Xiaowei Qi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaowei Qi has authored 199 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 71 papers in Oncology and 51 papers in Cancer Research. Recurrent topics in Xiaowei Qi's work include Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (15 papers) and Cancer-related molecular mechanisms research (14 papers). Xiaowei Qi is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (15 papers) and Cancer-related molecular mechanisms research (14 papers). Xiaowei Qi collaborates with scholars based in China, United States and Japan. Xiaowei Qi's co-authors include Jun Jiang, Yi Zhang, Wei Sun, Yuan Yin, Hongwei Gao, Long Yuan, Linfang Jin, Yong Mao, Dong Hua and Junlan Liu and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Xiaowei Qi

188 papers receiving 3.7k citations

Hit Papers

Epigenetic regulation of diverse cell death modalities in... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
    2024 73 citations Xiaowei Qi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Qi China 33 1.9k 1.3k 835 425 390 199 3.8k
Hua Guo China 38 2.4k 1.2× 1.2k 0.9× 816 1.0× 436 1.0× 513 1.3× 161 4.5k
Xiaomei Yang China 37 2.0k 1.0× 969 0.7× 583 0.7× 376 0.9× 215 0.6× 111 3.6k
Ping Sun China 31 1.3k 0.7× 945 0.7× 680 0.8× 283 0.7× 294 0.8× 170 3.4k
Wen Xu China 32 1.8k 0.9× 747 0.6× 1.1k 1.3× 672 1.6× 243 0.6× 157 4.2k
Hongyi Zhang China 31 1.7k 0.9× 775 0.6× 724 0.9× 279 0.7× 264 0.7× 154 4.2k
Ya Zhang China 35 3.0k 1.5× 1.8k 1.4× 1.4k 1.7× 599 1.4× 302 0.8× 184 5.7k
Chang Zou China 33 2.1k 1.1× 1.1k 0.8× 997 1.2× 547 1.3× 451 1.2× 120 3.9k
Chen Yang China 28 2.0k 1.0× 1.4k 1.1× 748 0.9× 568 1.3× 243 0.6× 121 3.6k
Lili Wang China 36 2.7k 1.4× 2.0k 1.6× 418 0.5× 451 1.1× 276 0.7× 172 4.3k
Hua Chen China 30 1.7k 0.9× 854 0.7× 876 1.0× 272 0.6× 136 0.3× 90 3.6k

Countries citing papers authored by Xiaowei Qi

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Qi more than expected).

Fields of papers citing papers by Xiaowei Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Qi. The network helps show where Xiaowei Qi may publish in the future.

Co-authorship network of co-authors of Xiaowei Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Qi. A scholar is included among the top collaborators of Xiaowei Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Qi. Xiaowei Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yan, Mengsi Zhang, Ji‐Hong Liu, et al.. (2025). Novel therapeutic strategies for targeting fatty acid oxidation in cancer. Biomarker Research. 13(1). 145–145.
3.
Liu, Huan, et al.. (2025). B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167771–167771. 1 indexed citations
4.
Yu, Xiaofeng, Lijun Suo, Li Wang, et al.. (2024). Analysis of clinical characteristics and mortality risk factors in patients with community-acquired pneumonia caused by Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease. 111(3). 116660–116660.
5.
Yang, Chen, Fang Zheng, Guifang Li, et al.. (2024). METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer. Journal of Translational Medicine. 22(1). 1161–1161. 12 indexed citations
6.
Wang, Li, et al.. (2024). A pan‐cancer analysis of Wnt family member 7B in human cancers. SHILAP Revista de lepidopterología. 3(5). e139–e139. 3 indexed citations
7.
Li, Wei, Chuanyu Yang, Zhuo Cheng, et al.. (2024). Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity. SHILAP Revista de lepidopterología. 5(8). e665–e665. 1 indexed citations
8.
9.
Sun, Na, Cheng Wang, Pingping Gao, et al.. (2024). Multifaceted roles and functions of SOX30 in human cancer. PubMed. 3(2). e107–e107. 2 indexed citations
10.
Liu, Quan, et al.. (2024). Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity. Journal of Separation Science. 47(11). e2400164–e2400164. 3 indexed citations
11.
12.
Wang, Hairui, Hui Wang, Rui Wang, et al.. (2024). Discovery of a molecular glue for EGFR degradation. Oncogene. 44(8). 545–556. 9 indexed citations
13.
Wen, Huizhong, Limeng Dai, Xiaojing Yan, et al.. (2023). A brain-tumor neural circuit controls breast cancer progression in mice. Journal of Clinical Investigation. 133(24). 30 indexed citations
14.
Wang, Yu, Qianmei Wang, Xiaowen Wang, et al.. (2023). Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer. Journal of Nanobiotechnology. 21(1). 286–286. 23 indexed citations
15.
Mi, Yuanyuan, Yu Ji, Lifeng Zhang, et al.. (2023). A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo. Cell Death and Disease. 14(1). 67–67. 16 indexed citations
16.
Sun, Fengjun, Yu Wang, Qianmei Wang, et al.. (2022). Self-Illuminating Triggered Release of Therapeutics from Photocleavable Nanoprodrug for the Targeted Treatment of Breast Cancer. ACS Applied Materials & Interfaces. 14(7). 8766–8781. 8 indexed citations
17.
Wang, Yu, Qianmei Wang, Wei Feng, et al.. (2021). Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment. Drug Delivery. 28(1). 1695–1708. 34 indexed citations
18.
Qi, Xiaowei, Linjun Fan, Li Chen, et al.. (2020). Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I–III HER2-Positive Breast Cancer: A Phase II Clinical Trial. The Oncologist. 25(12). e1909–e1920. 31 indexed citations
19.
20.
Li, Yao, Baoquan Hu, Xiujuan Wu, et al.. (2018). Adherence to Mediterranean diet and the risk of breast cancer: a meta-analysis. Translational Cancer Research. 7(5). 1290–1297. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Guo Breakdown of academic impact, for papers by Xiaomei Yang Breakdown of academic impact, for papers by Ping Sun Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Hongyi Zhang Breakdown of academic impact, for papers by Ya Zhang Breakdown of academic impact, for papers by Chang Zou Breakdown of academic impact, for papers by Chen Yang Breakdown of academic impact, for papers by Lili Wang Breakdown of academic impact, for papers by Hua Chen
Rankless by CCL
2026